From: Estimating the standardized incidence ratio (SIR) with incomplete follow-up data
 |  | Male |  | Female | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Observed | Expected SIR 95% confidence interval | Observed | Expected SIR 95% confidence interval | ||||||
 |  | Model 1 | Model 2 | Model 3 | Model 4 |  | Model 1 | Model 2 | Model 3 | Model 4 |
Person-years | Â | 81,193.4 | 74,377.9 | 84,907.6 | 90,510.7 | Â | 86,557.7 | 79,308.5 | 90,505.8 | 96,200.2 |
All Cancersa | 235 | 211.0 1.11 0.98, 1.27 | 189.0 1.24 1.09, 1.41 | 226.2 1.04 0.91, 1.18 | 261.1 0.90 0.79, 1.02 | 235 | 232.0 1.01 0.89, 1.15 | 209.7 1.12 0.99, 1.27 | 244.2 0.96 0.85, 1.09 | 274.5 0.86 0.75, 0.97 |
Stomach | 27 | 8.3 3.25 2.14, 4.75 | 7.5 3.60 2.37, 5.26 | 8.8 3.07 2.02, 4.48 | 10.5 2.57 1.68, 3.75 | 21 | 6.8 3.09 1.91, 4.73 | 6.1 3.44 2.13, 5.27 | 7.1 2.96 1.83, 4.53 | 8.4 2.50 1.55, 3.83 |
Colorectal | 18 | 31.0 0.58 0.34, 0.92 | 27.6 0.65 0.39, 1,03 | 32.8 0.55 0.33, 0.87 | 39.1 0.46 0.27, 0.73 | 39 | 31.9 1.22 0.87, 1.67 | 28.6 1.36 0.97, 1.86 | 33.6 1.16 0.83, 1.59 | 39.2 0.99 0.71, 1.36 |
Lung | 61 | 36.2 1.69 1.31, 2.17 | 32.4 1.88 1.46, 2.42 | 38.3 1.59 1.24, 2.05 | 45.0 1.36 1.05, 1.74 | 6 | 15.7 0.38 0.14, 0.83 | 14.1 0.43 0.16, 0.93 | 16.6 0.36 013, 0,79 | 18.5 0.32 0.12, 0.71 |
Breast | Â | Â | Â | Â | Â | 57 | 72.1 0.79 0.61, 1.02 | 65.3 0.87 0.67, 1.13 | 75.8 0.75 0.58, 0.97 | 83.6 0.68 0.53, 0.88 |
Prostate | 35 | 37.6 0.93 0.65, 1.29 | 33.3 1.05 0.73, 1.46 | 40.0 0.88 0.61, 1.22 | 48.7 0.72 0.50, 1.00 | Â | Â | Â | Â | Â |
Leukaemia | 9 | 5.9 1.53 0.70, 2.90 | 5.4 1.67 0.76, 3.17 | 6.3 1.43 0.65, 2.71 | 7.1 1.27 0.58, 2.41 | 7 | 5.2 1.35 0.54, 2.77 | 4.7 1.49 0.60, 3.07 | 5.5 1.27 0.51, 2.62 | 6.2 1.13 0.45, 2.33 |